{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:42:07Z","timestamp":1794264127603,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Yunnan Ten Thousand Youth Talent Program","award":["[2018]73"],"award-info":[{"award-number":["[2018]73"]}]},{"name":"the Medical Discipline Leader in Health Commission of Yunnan Province","award":["D-2019004"],"award-info":[{"award-number":["D-2019004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasingly studies reported that the Anti-M\u00fcllerian hormone (AMH) seems to be a promising and reliable marker of functional ovarian follicle reserve, even better than the AFC test. Our study aimed to conduct a meta-analysis to assess the predictive value of AMH and AFC for predicting poor or high response in IVF treatment. An electronic search was conducted, and the following databases were used: PubMed, EMBASE, and the Cochrane Library (up to 7 May 2022). The bivariate regression model was used to calculate the pooled sensitivity, specificity, and area under the receiver operator characteristic (ROC) curve. Subgroup analyses and meta-regression also were used in the presented study. Overall performance was assessed by estimating pooled ROC curves between AMH and AFC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-two studies were eligible for this meta-analysis. Comparison of the summary estimates for the prediction of poor or high response showed significant difference in performance for AMH compared with AFC [poor (sensitivity: 0.80 vs 0.74,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.050; specificity: 0.81 vs 0.85,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001); high (sensitivity: 0.81 vs 0.87,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001)]. However, there were no significant differences between the ROC curves of AMH and AFC for predicting high (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.835) or poor response (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.567). The cut-off value was a significant source of heterogeneity in the present study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The present meta-analysis demonstrated that both AMH and AFC have a good predictive ability to the prediction of poor or high responses in IVF treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13048-023-01202-5","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T03:01:58Z","timestamp":1687834918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Comparison of anti-M\u00fcllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"16","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengmei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"1202_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/humupd\/dmt037","volume":"20","author":"A La Marca","year":"2014","unstructured":"La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update. 2014;20:124\u201340.","journal-title":"Hum Reprod Update"},{"key":"1202_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fendo.2019.00325","volume":"10","author":"J Huang","year":"2019","unstructured":"Huang J, Lin J, Gao H, Wang Y, Zhu X, Lu X, et al. Anti-m\u00fcllerian hormone for the prediction of ovarian response in progestin-primed ovarian stimulation protocol for IVF. Front Endocrinol (Lausanne). 2019;10:325.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1202_CR3","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1093\/humrep\/dem101","volume":"22","author":"S Tsepelidis","year":"2007","unstructured":"Tsepelidis S, Devreker F, Demeestere I, Flahaut A, Gervy C, Englert Y. Stable serum levels of anti-M\u00fcllerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod. 2007;22:1837\u201340.","journal-title":"Hum Reprod"},{"key":"1202_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humupd\/dmt062","volume":"20","author":"D Dewailly","year":"2014","unstructured":"Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update. 2014;20:370\u201385.","journal-title":"Hum Reprod Update"},{"key":"1202_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1023\/A:1009424407082","volume":"18","author":"R Nahum","year":"2001","unstructured":"Nahum R, Shifren JL, Chang Y, Leykin L, Isaacson K, Toth TL. Antral follicle assessment as a tool for predicting outcome in IVF\u2013is it a better predictor than age and FSH? J Assist Reprod Genet. 2001;18:151\u20135.","journal-title":"J Assist Reprod Genet"},{"key":"1202_CR6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0015-0282(01)02983-1","volume":"77","author":"LF Bancsi","year":"2002","unstructured":"Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril. 2002;77:328\u201336.","journal-title":"Fertil Steril"},{"key":"1202_CR7","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1093\/humupd\/dmu020","volume":"20","author":"SL Broer","year":"2014","unstructured":"Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-M\u00fcllerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20:688\u2013701.","journal-title":"Hum Reprod Update"},{"key":"1202_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10815-019-01622-7","volume":"37","author":"J Bedenk","year":"2020","unstructured":"Bedenk J, Vrta\u010dnik-Bokal E, Virant-Klun I. The role of anti-M\u00fcllerian hormone (AMH) in ovarian disease and infertility. J Assist Reprod Genet. 2020;37:89\u2013100.","journal-title":"J Assist Reprod Genet"},{"key":"1202_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/molehr\/gah015","volume":"10","author":"C Weenen","year":"2004","unstructured":"Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-M\u00fcllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod. 2004;10:77\u201383.","journal-title":"Mol Hum Reprod"},{"key":"1202_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-013-9975-3","volume":"30","author":"MF Mutlu","year":"2013","unstructured":"Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, et al. Antral follicle count determines poor ovarian response better than anti-M\u00fcllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30:657\u201365.","journal-title":"J Assist Reprod Genet"},{"key":"1202_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4103\/jhrs.JHRS_15_16","volume":"10","author":"R Vembu","year":"2017","unstructured":"Vembu R, Reddy NS. Serum AMH level to predict the hyper response in women with PCOS and non-PCOS undergoing controlled ovarian stimulation in ART. J Hum Reprod Sci. 2017;10:91\u20134.","journal-title":"J Hum Reprod Sci"},{"key":"1202_CR12","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10815-011-9627-4","volume":"28","author":"P Ocal","year":"2011","unstructured":"Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-M\u00fcllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28:1197\u2013203.","journal-title":"J Assist Reprod Genet"},{"key":"1202_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, D\u00f3lleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17:46\u201354.","journal-title":"Hum Reprod Update"},{"key":"1202_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91:705\u201314.","journal-title":"Fertil Steril"},{"key":"1202_CR15","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"1202_CR16","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529\u201336.","journal-title":"Ann Intern Med"},{"key":"1202_CR17","first-page":"461","volume":"63","author":"MB Palhares","year":"2018","unstructured":"Palhares MB, Martins WP, Rom\u00e3o GS, Ferriani RA, Navarro PA. Combining age, antral follicle count, anti-M\u00fcllerian hormone, and follicle-stimulating hormone is more accurate than individual markers in predicting poor ovarian response. J Reprod Med. 2018;63(5):461\u20136.","journal-title":"J Reprod Med"},{"key":"1202_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3109\/14647273.2011.608464","volume":"14","author":"A Tolikas","year":"2011","unstructured":"Tolikas A, Tsakos E, Gerou S, Prapas Y, Loufopoulos A. Anti-Mullerian hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles. Hum Fertil. 2011;14:246\u201353.","journal-title":"Hum Fertil"},{"key":"1202_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10815-009-9319-5","volume":"26","author":"A Aflatoonian","year":"2009","unstructured":"Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Prediction of high ovarian response to controlled ovarian hyperstimulation: anti-M\u00fcllerian hormone versus small antral follicle count (2\u20136 mm). J Assist Reprod Genet. 2009;26:319\u201325.","journal-title":"J Assist Reprod Genet"},{"key":"1202_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1080\/01443615.2016.1225025","volume":"37","author":"M Ashrafi","year":"2017","unstructured":"Ashrafi M, Hemat M, Arabipoor A, Salman Yazdi R, Bahman-Abadi A, Cheraghi R. Predictive values of anti-m\u00fcllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes. J Obstet Gynaecol. 2017;37(1):82\u20138.","journal-title":"J Obstet Gynaecol"},{"key":"1202_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.fertnstert.2021.01.056","volume":"116","author":"VL Baker","year":"2021","unstructured":"Baker VL, Glassner MJ, Doody K, Schnell VL, Gracia C, Shin SS, et al. Validation study of the Access antim\u00fcllerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2021;116:575\u201382.","journal-title":"Fertil Steril"},{"key":"1202_CR22","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.fertnstert.2018.03.031","volume":"110","author":"VL Baker","year":"2018","unstructured":"Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, et al. Multicenter evaluation of the Access AMH antim\u00fcllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2018;110:506-13.e3.","journal-title":"Fertil Steril"},{"key":"1202_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.fertnstert.2003.06.011","volume":"81","author":"LFJMM Bancsi","year":"2004","unstructured":"Bancsi LFJMM, Broekmans FJM, Looman CWN, Habbema JDF, Te Velde ER. Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril. 2004;81:35\u201341.","journal-title":"Fertil Steril"},{"key":"1202_CR24","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.1093\/humrep\/dei203","volume":"20","author":"T Eldar-Geva","year":"2005","unstructured":"Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, Markowitz E, Mimoni T, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod. 2005;20:3178\u201383.","journal-title":"Hum Reprod"},{"key":"1202_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/humrep\/dey244","volume":"33","author":"F Fabregues","year":"2018","unstructured":"Fabregues F, Gonzalez-Foruria I, Pe\u00f1arrubia J, Carmona F. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF. Hum Reprod. 2018;33:1696\u2013704.","journal-title":"Hum Reprod"},{"key":"1202_CR26","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","volume":"85","author":"C Fi\u00e7icioglu","year":"2006","unstructured":"Fi\u00e7icioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006;85:592\u20136.","journal-title":"Fertil Steril"},{"key":"1202_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mefs.2010.06.009","volume":"15","author":"F Fouda","year":"2010","unstructured":"Fouda F, Rezk AY, Razik MA, El-Shair O, Salim A. Anti-mullerian hormone level is a reliable predictor for cycle cancellation in ICSI. Middle East Fertil Soc J. 2010;15:194\u20139.","journal-title":"Middle East Fertil Soc J"},{"key":"1202_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S0015-0282(03)00664-2","volume":"80","author":"JL Frattarelli","year":"2003","unstructured":"Frattarelli JL, Levi AJ, Miller BT, Segars JH. A prospective assessment of the predictive value of basal antral follicles in in vitro fertilization cycles. Fertil Steril. 2003;80:350\u20135.","journal-title":"Fertil Steril"},{"key":"1202_CR29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/humrep\/den108","volume":"23","author":"C Gnoth","year":"2008","unstructured":"Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008;23:1359\u201365.","journal-title":"Hum Reprod"},{"key":"1202_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s40618-015-0297-4","volume":"38","author":"Z Heidar","year":"2015","unstructured":"Heidar Z, Bakhtiyari M, Mirzamoradi M, Zadehmodarres S, Sarfjoo FS, Mansournia MA. Prediction of different ovarian responses using anti-M\u00fcllerian hormone following a long agonist treatment protocol for IVF. J Endocrinol Invest. 2015;38:1007\u201315.","journal-title":"J Endocrinol Invest"},{"key":"1202_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mefs.2015.08.005","volume":"21","author":"Y Islam","year":"2016","unstructured":"Islam Y, Aboulghar MM, Alebrashy AED, Abdel-Aziz O. The value of different ovarian reserve tests in the prediction of ovarian response in patients with unexplained infertility. Middle East Fertil Soc J. 2016;21(2):69\u201374.","journal-title":"Middle East Fertil Soc J"},{"key":"1202_CR32","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.15557\/JoU.2021.0032","volume":"21","author":"R Izhar","year":"2021","unstructured":"Izhar R, Husain S, Tahir MA, Kausar M, Sana T, Ghalib F. Antral follicle count and anti-m\u00fcllerian hormone level as predictors of ovarian hyperstimulation syndrome in women with polycystic ovarian syndrome undergoing controlled ovarian stimulation. J Ultrason. 2021;21:e200\u20135.","journal-title":"J Ultrason"},{"key":"1202_CR33","first-page":"816","volume":"102","author":"IY J\u00e4rvel\u00e4","year":"2003","unstructured":"J\u00e4rvel\u00e4 IY, Sladkevicius P, Kelly S, Ojha K, Campbell S, Nargund G. Quantification of ovarian power Doppler signal with three-dimensional ultrasonography to predict response during in vitro fertilization. Obstet Gynecol. 2003;102:816\u201322.","journal-title":"Obstet Gynecol"},{"key":"1202_CR34","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.fertnstert.2008.10.042","volume":"93","author":"K Jayaprakasan","year":"2010","unstructured":"Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-M\u00fcllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril. 2010;93:855\u201364.","journal-title":"Fertil Steril"},{"key":"1202_CR35","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1093\/humrep\/dem104","volume":"22","author":"K Jayaprakasan","year":"2007","unstructured":"Jayaprakasan K, Hilwah N, Kendall NR, Hopkisson JF, Campbell BK, Johnson IR, et al. Does 3D ultrasound offer any advantage in the pretreatment assessment of ovarian reserve and prediction of outcome after assisted reproduction treatment? Hum Reprod. 2007;22:1932\u201341.","journal-title":"Hum Reprod"},{"key":"1202_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12958-015-0049-5","volume":"13","author":"J Knez","year":"2015","unstructured":"Knez J, Kova\u010di\u010d B, Medved M, Vlaisavljevi\u0107 V. What is the value of anti-M\u00fcllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols? Reprod Biol Endocrinol. 2015;13:58.","journal-title":"Reprod Biol Endocrinol"},{"key":"1202_CR37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00404-011-1889-7","volume":"283","author":"C Kunt","year":"2011","unstructured":"Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, et al. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. Arch Gynecol Obstet. 2011;283:1415\u201321.","journal-title":"Arch Gynecol Obstet"},{"key":"1202_CR38","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/humrep\/del421","volume":"22","author":"A La Marca","year":"2007","unstructured":"La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, et al. Anti-M\u00fcllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod (Oxford, England). 2007;22:766\u201371.","journal-title":"Hum Reprod (Oxford, England)"},{"key":"1202_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1477-7827-9-115","volume":"9","author":"RK Lee","year":"2011","unstructured":"Lee RK, Wu FS, Lin MH, Lin SY, Hwu YM. The predictability of serum anti-M\u00fcllerian level in IVF\/ICSI outcomes for patients of advanced reproductive age. Reprod Biol Endocrinol. 2011;9:115.","journal-title":"Reprod Biol Endocrinol"},{"key":"1202_CR40","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/humrep\/dem254","volume":"23","author":"TH Lee","year":"2008","unstructured":"Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-m\u00fcllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160\u20137.","journal-title":"Hum Reprod"},{"key":"1202_CR41","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.rbmo.2016.07.003","volume":"33","author":"R Li","year":"2016","unstructured":"Li R, Gong F, Zhu Y, Fang W, Yang J, Liu J, et al. Anti-M\u00fcllerian hormone for prediction of ovarian response in Chinese infertile women undergoing IVF\/ICSI cycles: a prospective, multi-centre, observational study. Reprod Biomed Online. 2016;33:506\u201312.","journal-title":"Reprod Biomed Online"},{"key":"1202_CR42","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3109\/09513590.2013.801443","volume":"29","author":"F Mart\u00ednez","year":"2013","unstructured":"Mart\u00ednez F, Clua E, Carreras O, Tur R, Rodr\u00edguez I, Barri PN. Is AMH useful to reduce low ovarian response to GnRH antagonist protocol in oocyte donors? Gynecol Endocrinol. 2013;29:754\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1202_CR43","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/humrep\/del435","volume":"22","author":"M McIlveen","year":"2007","unstructured":"McIlveen M, Skull JD, Ledger WL. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population. Hum Reprod. 2007;22:778\u201385.","journal-title":"Hum Reprod"},{"key":"1202_CR44","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1111\/j.1471-0528.2004.00452.x","volume":"111","author":"S Muttukrishna","year":"2004","unstructured":"Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF\/ICSI patients? BJOG. 2004;111:1248\u201353.","journal-title":"BJOG"},{"key":"1202_CR45","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1472-6483(10)60892-9","volume":"14","author":"GS Nakhuda","year":"2007","unstructured":"Nakhuda GS, Sauer MV, Wang JG, Ferin M, Lobo RA. M\u00fcllerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF. Reprod Biomed Online. 2007;14:450\u20134.","journal-title":"Reprod Biomed Online"},{"key":"1202_CR46","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","volume":"92","author":"LG Nardo","year":"2009","unstructured":"Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti-M\u00fcllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92:1586\u201393.","journal-title":"Fertil Steril"},{"key":"1202_CR47","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/humrep\/dem204","volume":"22","author":"SM Nelson","year":"2007","unstructured":"Nelson SM, Yates RW, Fleming R. Serum anti-M\u00fcllerian hormone and FSH: Prediction of live birth and extremes of response in stimulated cycles - Implications for individualization of therapy. Hum Reprod. 2007;22:2414\u201321.","journal-title":"Hum Reprod"},{"key":"1202_CR48","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.rbmo.2020.03.023","volume":"41","author":"AR Neves","year":"2020","unstructured":"Neves AR, Blockeel C, Griesinger G, Garcia-Velasco JA, Marca A, Rodriguez I, et al. The performance of the Elecsys\u00ae anti-M\u00fcllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa. Reprod Biomed Online. 2020;41:29\u201336.","journal-title":"Reprod Biomed Online"},{"key":"1202_CR49","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/humrep\/deh718","volume":"20","author":"J Pe\u00f1arrubia","year":"2005","unstructured":"Pe\u00f1arrubia J, F\u00e1bregues F, Manau D, Creus M, Casals G, Casamitjana R, et al. Basal and stimulation day 5 anti-M\u00fcllerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod. 2005;20:915\u201322.","journal-title":"Hum Reprod"},{"key":"1202_CR50","first-page":"115","volume":"15","author":"AA Sene","year":"2021","unstructured":"Sene AA, Ashrafi M, Alaghmand-Fard N, Mohammadi N, Alisaraie MM, Alizadeh A. Anti-m\u00fcllerian hormone predictive levels to determine the likelihood of ovarian hyper-response in infertile women with polycystic ovarian morphology. Int J Fertil Ster. 2021;15:115\u201322.","journal-title":"Int J Fertil Ster"},{"key":"1202_CR51","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s13224-012-0318-6","volume":"63","author":"N Singh","year":"2013","unstructured":"Singh N, Malik E, Banerjee A, Chosdol K, Sreenivas V, Mittal S. \u201canti-mullerian hormone: marker for ovarian response in controlled ovarian stimulation for IVF patients\u201d: a first pilot study in the Indian population. J Obstet Gynecol India. 2013;63:268\u201372.","journal-title":"J Obstet Gynecol India"},{"key":"1202_CR52","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/09513590701253776","volume":"23","author":"PNB Soldevila","year":"2007","unstructured":"Soldevila PNB, Carreras O, Tur R, Coroleu B, Barri PN. Sonographic assessment of ovarian reserve. Its correlation with outcome of in vitro fertilization cycles. Gynecol Endocrinol. 2007;23:206\u201312.","journal-title":"Gynecol Endocrinol"},{"key":"1202_CR53","doi-asserted-by":"publisher","first-page":"7822119","DOI":"10.1155\/2021\/7822119","volume":"2021","author":"X Tan","year":"2021","unstructured":"Tan X, Xi H, Yang J, Wang W. Development and validation of prediction model for high ovarian response in in vitro fertilization-embryo transfer: a longitudinal study. Comput Math Methods Med. 2021;2021:7822119.","journal-title":"Comput Math Methods Med"},{"key":"1202_CR54","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1479-828X.2005.00332.x","volume":"45","author":"KP Tremellen","year":"2005","unstructured":"Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti-mullerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 2005;45:20\u20134.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"1202_CR55","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","volume":"17","author":"IAJ Van Rooij","year":"2002","unstructured":"Van Rooij IAJ, Broekmans FJM, Te Velde ER, Fauser BCJM, Bancsi LFJMM, De Jong FH, et al. Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002;17:3065\u201371.","journal-title":"Hum Reprod"},{"key":"1202_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/humrep\/deg019","volume":"18","author":"PY Yong","year":"2003","unstructured":"Yong PY, Baird DT, Thong KJ, McNeilly AS, Anderson RA. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod. 2003;18:35\u201344.","journal-title":"Hum Reprod"},{"issue":"10","key":"1202_CR57","first-page":"1717","volume":"60","author":"HM Kamel","year":"2014","unstructured":"Kamel HM, Amin AH, Al-Adawy AR. Basal serum anti-Mullerian hormone (AMH) is a promising test in prediction of occurrence of pregnancy rate in infertile women undergoing ICSI cycles. Clin Lab. 2014;60(10):1717\u201323.","journal-title":"Clin Lab"},{"key":"1202_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","volume":"100","author":"NP Polyzos","year":"2013","unstructured":"Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2013;100:430\u20137.","journal-title":"Fertil Steril"},{"issue":"1","key":"1202_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43043-021-00062-7","volume":"26","author":"MM Laqqan","year":"2021","unstructured":"Laqqan MM, Yassin MM. Predictive factors of ovarian response to GnRH antagonist stimulation protocol: AMH and age are potential candidates. Middle East Fertil Soc J. 2021;26(1):1\u20131.","journal-title":"Middle East Fertil Soc J"},{"key":"1202_CR60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10815-011-9675-9","volume":"29","author":"H Honnma","year":"2012","unstructured":"Honnma H, Baba T, Sasaki M, Hashiba Y, Oguri H, Fukunaga T, et al. Different ovarian response by age in an anti-M\u00fcllerian hormone-matched group undergoing in vitro fertilization. J Assist Reprod Genet. 2012;29:117\u201325.","journal-title":"J Assist Reprod Genet"},{"key":"1202_CR61","first-page":"216","volume":"33","author":"Y He","year":"2013","unstructured":"He Y, Xia R, Chen X, Ye D, Tang Y, Li P, et al. Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:216\u201320.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1202_CR62","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/humrep\/den219","volume":"23","author":"MF Verberg","year":"2008","unstructured":"Verberg MF, Eijkemans MJ, Heijnen EM, Broekmans FJ, de Klerk C, Fauser BC, et al. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod. 2008;23:2050\u20135.","journal-title":"Hum Reprod"},{"key":"1202_CR63","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","volume":"31","author":"R Fleming","year":"2015","unstructured":"Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone. Reprod Biomed Online. 2015;31:486\u201396.","journal-title":"Reprod Biomed Online"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01202-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01202-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T15:03:14Z","timestamp":1687878194000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01202-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1202"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01202-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}